Literature DB >> 16166206

Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats.

Leith C R Meyer1, Andrea Fuller, Duncan Mitchell.   

Abstract

Neurophysiological studies have shown that serotonergic ligands that bind to 5-HT1A, 5-HT7, and 5-HT4 serotonin receptors in brain stem have beneficial effects on respiratory neurons during opioid-induced respiratory depression. The effect of these ligands on respiratory function and pulmonary performance has not been studied. We therefore examined the effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), an agonist of 5-HT1A and 5-HT7 receptors, and zacopride, an agonist of 5-HT4 receptors, to establish whether these ligands would reverse opioid-induced respiratory depression and hypoxia without affecting the immobilizing properties of the opioid drug etorphine. When etorphine was used to sedate and immobilize goats, it significantly decreased respiratory rate (P = 0.013), percent hemoglobin oxygen saturation (P < 0.0001), and arterial oxygen partial pressure [Pa(O2); F(10,70) = 5.67, P < 0.05] and increased arterial carbon dioxide partial pressure [F(10,70) = 3.87, P < 0.05] and alveolar-arterial oxygen partial pressure gradient [A-a gradients; F(10,70) = 8.23, P < 0.0001]. Zacopride and 8-OH-DPAT, coadministered with etorphine, both attenuated the effects of etorphine; respiration rates did not decrease, and percent hemoglobin oxygen saturation and Pa(O2) remained elevated. Zacopride decreased the hypercapnia, indicating an improvement in ventilation, whereas 8-OH-DPAT did not affect the hypercapnia and, therefore, did not improve ventilation. The main beneficial effect of 8-OH-DPAT was on the pulmonary circulation; it improved oxygen diffusion, indicated by the normal A-a gradients, presumably by improving ventilation perfusion ratios. Neither zacopride nor 8-OH-DPAT reversed etorphine-induced catatonic immobilization. We conclude that serotonergic drugs that act on 5-HT1A, 5-HT7, and 5-HT4 receptors reverse opioid-induced respiratory depression and hypoxia without reversing catatonic immobilization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166206     DOI: 10.1152/ajpregu.00440.2005

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  11 in total

1.  Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Authors:  L Y Yeung; H F Kung; David T Yew
Journal:  Age (Dordr)       Date:  2010-05-28

2.  CrossTalk opposing view: The pre-Botzinger complex is not essential for respiratory depression following systemic administration of opioid analgesics.

Authors:  Peter M Lalley; Paul M Pilowsky; Hubert V Forster; Edward J Zuperku
Journal:  J Physiol       Date:  2014-03-15       Impact factor: 5.182

3.  Dual effects of 5-HT(1a) receptor activation on breathing in neonatal mice.

Authors:  Andrea E Corcoran; Kathryn G Commons; Yuanming Wu; Jeffrey C Smith; Michael B Harris; George B Richerson
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

4.  Serotonin targets inhibitory synapses to induce modulation of network functions.

Authors:  Till Manzke; Mathias Dutschmann; Gerald Schlaf; Michael Mörschel; Uwe R Koch; Evgeni Ponimaskin; Olivier Bidon; Peter M Lalley; Diethelm W Richter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-12       Impact factor: 6.237

Review 5.  Understanding and countering opioid-induced respiratory depression.

Authors:  Jordan T Bateman; Sandy E Saunders; Erica S Levitt
Journal:  Br J Pharmacol       Date:  2021-06-05       Impact factor: 8.739

6.  A Comparison of Breathing Stimulants for Reversal of Synthetic Opioid-Induced Respiratory Depression in Conscious Rats.

Authors:  Kaye E Dandrea; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2021-05-21       Impact factor: 4.402

7.  Hypoxia following etorphine administration in goats (Capra hircus) results more from pulmonary hypertension than from hypoventilation.

Authors:  Leith Carl Rodney Meyer; Robyn Sheila Hetem; Duncan Mitchell; Andrea Fuller
Journal:  BMC Vet Res       Date:  2015-02-03       Impact factor: 2.741

8.  D-Amphetamine Accelerates Recovery of Consciousness and Respiratory Drive After High-Dose Fentanyl in Rats.

Authors:  Olivia A Moody; Edlyn R Zhang; Vipin Arora; Risako Kato; Joseph F Cotten; Ken Solt
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

9.  Glutathione ethyl ester reverses the deleterious effects of fentanyl on ventilation and arterial blood-gas chemistry while prolonging fentanyl-induced analgesia.

Authors:  Michael W Jenkins; Faiza Khalid; Santhosh M Baby; Walter J May; Alex P Young; James N Bates; Feixiong Cheng; James M Seckler; Stephen J Lewis
Journal:  Sci Rep       Date:  2021-03-26       Impact factor: 4.379

Review 10.  Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants.

Authors:  Mohammad Zafar Imam; Andy Kuo; Maree T Smith
Journal:  F1000Res       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.